Ontario Brain Injury Association (OBIA) Peer Support Program (TOPS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03450460 |
|
Recruitment Status :
Completed
First Posted : March 1, 2018
Last Update Posted : September 25, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Most people with moderate or severe TBI have difficulty returning to their usual social roles and activities. The OBIA has developed a program where peers (other individuals living with TBI) coach or mentor those with more recent brain injury. The objective of this project is to evaluate the feasibility of measuring the impact of the OBIA Peer Program on social participation and mood compared to a control group who have not received peer support yet.
The proposed study will involve three phases. It will begin with a qualitative component (stakeholder interviews), then a pilot RCT, and end with more interviews to explore the success of the study intervention. A qualitative descriptive approach will be used at these first and last phases of the study. In Phase 1, interviews will be conducted with approximately 15 participants including individuals with moderate to severe TBI, caregivers, Mentors, OBIA staff members, and health researchers. The proposed Phase 2 will be a clinical trial, conducted with 60 participants. These participants will be randomized to one of three groups: a twice a week Program (n=20), a once a week Program (n=20), or the wait list control group (n=20). For Phase 3, a sub group of approximately 25 participants from Phase 2 who participated in the OBIA Peer Support Program will be asked to participate in a one-on-one, telephone/Skype interview. A sub-group of Mentors will also be asked to participate in a one-on-one, telephone/Skype interview.
This research project will address the highest priority areas of "strategies to enhance social participation and community life (personal relationships)" and "psychological strategies to improve mood, depression, and irritability", as identified in the ONF's Request for Proposals on "Addressing Evidence Gaps in Moderate to Severe TBI Rehabilitation". The study will provide important results to inform a RCT (of appropriate size) on the impact of peer support on the social participation and mood of individuals with moderate to severe TBI. This study will then provide the best evidence to support the recommendation on "a peer-supported relationship model of intervention", and inform future versions of the INESSS-ONF Guideline.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Acquired Brain Injury | Behavioral: Peer support | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 13 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Supportive Care |
| Official Title: | A Randomized Controlled Feasibility Trial on the Ontario Brain Injury Association Peer Support Program |
| Actual Study Start Date : | May 16, 2018 |
| Actual Primary Completion Date : | February 13, 2020 |
| Actual Study Completion Date : | June 18, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: 1/week peer support
These individuals with acquired brain injury will receive the Ontario Brain Injury Association Peer Support program once per week.
|
Behavioral: Peer support
The Program matches volunteer Mentors and Partners for a series of one-to-one interactions that focus on the discussion and resolution of problems or issues (i.e., problem solving) related to one or several key topic areas including family and friends, resources, life changes or challenges, (health care) professionals, social/recreational activities, work/employment/training/volunteering, the brain injury itself, emotions or feelings, and other issues.27 Once the match is established, the Mentor and Partner communicate with one another primarily by telephone until the problems or issues are either resolved or a referral to another service is made (i.e., counselling or community support services). For some partnerships, communication by email or video conferencing is used.27 Most telephone calls last between 20 and 40 minutes (personal communication) and are held weekly. |
|
No Intervention: wait list control group
These individuals with acquired brain injury will receive the Ontario Brain Injury Association Peer Support once the trial period is complete.
|
- Change from Baseline Participation at 4 months [ Time Frame: Baseline to 4 months ]Community Integration Questionnaire (CIQ)
- Change from Baseline Mood at 4 months [ Time Frame: Baseline to 4 months ]Patient Health Questionnaire-9
- Change from Health-related Quality of Life at 4 months [ Time Frame: Baseline to 4 months ]Short-Form-20 Health Survey
- Change from Self-efficacy at 4 months [ Time Frame: Baseline to 4 months ]Traumatic Brain Injury Self-efficacy Questionnaire
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 99 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Gender Based Eligibility: | Yes |
| Accepts Healthy Volunteers: | No |
For Phase 1
Inclusion Criteria
Partner participants, including caregiver Partners,
- Community-based (i.e., no longer participating in a comprehensive rehabilitation program) individuals;
- Have a moderate to severe TBI (Glasgow Coma Scale ≤12) or have cared for (i.e., unpaid) an individual with moderate to severe TBI for at least one year;
- Are 18 years of age or older;
- Have participated in the OBIA Peer Support Program;
- Are fluent in English; and,
- Are able to provide informed consent/have an available proxy who is able to provide informed consent.
Mentor participants -Completed at least one partnership with the OBIA Peer Support Program
Exclusion Criteria
Partner participants, including caregiver Partners,
-Individuals who are medically unstable or have active suicidal ideation
For Phase 2 and 3
Inclusion Criteria
Partner/Mentor participants
- Community-based (i.e., no longer participating in a comprehensive rehabilitation program);
- Have a moderate to severe TBI (Glasgow Coma Scale of 12 or less);
- Are 18 years of age or older;
- Are fluent in English; and,
-
Are able to provide informed consent/have an available proxy who is able to provide informed consent.
- Note that Mentor participants may include newly-trained Mentors or Mentors that have already had previous mentorship experience with the OBIA Peer Support Program.
Exclusion Criteria
- Previously participated in the OBIA Peer Support Program or currently receiving peer support/self-management program elsewhere;
- Are medically unstable; and,
- Have active suicidal ideation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03450460
| Canada, Ontario | |
| Ontario Brain Injury Association | |
| Toronto, Ontario, Canada | |
| Principal Investigator: | Sarah Munce | Toronto Rehabilitation, University Health Network |
| Responsible Party: | Sarah Munce, Scientist, University Health Network, Toronto |
| ClinicalTrials.gov Identifier: | NCT03450460 |
| Other Study ID Numbers: |
TorontoRI |
| First Posted: | March 1, 2018 Key Record Dates |
| Last Update Posted: | September 25, 2020 |
| Last Verified: | September 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
peer support feasibility trial mixed methods |
|
Brain Injuries Wounds and Injuries Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Craniocerebral Trauma Trauma, Nervous System |

